Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

ZBIOZBIO
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in ZENAS BIOPHARMA INC

Yes. Vanguard Portfolio Management holds 304,870 shares of ZBIO (Zenas Biopharma), worth $7.7M, as of its Q2 2026 13F filing. It increased the position by 53,460 shares (+21.3%) from Q1 2026. Vanguard Portfolio Management has held ZBIO in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$7.7M

Current Shares

304,870

Total Value Change

+$2.8M

Total Shares Change

+53,460

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
304,870
+21.3%
$7.7M0.0%$25.38
33
2026-Q1
First report
251,410
-
$4.9M0.0%$25.18
0

Other major holders of ZBIO: FMR LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used